Lipoarabinomannan

A glycolipid found in the cell walls of mycobacteria

Lipoarabinomannan (LAM) is a complex glycolipid found in the cell walls of mycobacteria, including the pathogenic species Mycobacterium tuberculosis, which causes tuberculosis. LAM plays a crucial role in the interaction between the mycobacteria and the host's immune system, influencing the pathogenesis of mycobacterial infections.

Structure

LAM is a heterogeneous molecule composed of a lipid anchor, a mannan core, and an arabinofuranose-rich outer domain. The lipid anchor is embedded in the mycobacterial cell membrane, while the carbohydrate moieties extend outward. The mannan core is linked to the lipid anchor via a phosphatidyl-myo-inositol linkage, forming the basis of the phosphatidylinositol mannoside (PIM) structure. The arabinan domain is attached to the mannan core and is highly branched, contributing to the molecule's complexity and variability.

Function

LAM is involved in modulating the host immune response. It can inhibit the activation of macrophages and dendritic cells, which are crucial for the immune system's ability to respond to infections. By interfering with these cells, LAM helps mycobacteria evade the host's immune defenses, allowing the bacteria to persist within the host.

LAM also plays a role in the formation of granulomas, which are organized structures of immune cells that form in response to chronic infection. Granulomas are characteristic of tuberculosis and serve to contain the infection, although they also provide a niche where mycobacteria can survive.

Biosynthesis

The biosynthesis of LAM involves several enzymatic steps, starting with the synthesis of the lipid anchor and the mannan core. The arabinan domain is then added through the action of specific glycosyltransferases. The biosynthetic pathway is complex and involves multiple genes and enzymes, making it a potential target for antimycobacterial drugs.

Biosynthetic pathway of ManLAM

Clinical Significance

LAM is a key virulence factor in mycobacterial infections. Its ability to modulate the immune response makes it a target for vaccine development and diagnostic tests. Detection of LAM in urine is used as a diagnostic tool for tuberculosis, particularly in HIV-positive individuals, who are at higher risk for disseminated mycobacterial infections.

Research and Development

Ongoing research aims to better understand the structure and function of LAM, as well as its role in mycobacterial pathogenesis. Efforts are also underway to develop new therapeutic strategies targeting LAM, including vaccines and drugs that can disrupt its synthesis or function.

Related pages

• Mycobacterium tuberculosis
• Tuberculosis
• Glycolipid
• Immune system